Literature DB >> 11106887

Combined evidence from multiple outcomes in a clinical trial.

H J Schouten1.   

Abstract

Clinical investigators are encouraged to apply recently developed statistical methodology. For each patient in a trial, favorable and unfavorable results from multiple outcomes may be summarized in a suitable summary measure. This summary measure may be used in a two-sample t-test to decide which treatment is best. An example illustrates how the evidence from the main outcome criteria may be combined. The required study size depends on the mean treatment effect on the outcomes in the summary measure. When separate outcomes are considered, there is a multiple comparisons problem, for which Hochberg offered a simple solution. Evaluation of a single-summary measure may require a larger or a smaller study size than evaluation of separate outcomes, depending on whether treatment effects are about the same or very different.

Entities:  

Mesh:

Year:  2000        PMID: 11106887     DOI: 10.1016/s0895-4356(00)00238-9

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  4 in total

1.  Didgeridoo playing as alternative treatment for obstructive sleep apnoea syndrome: randomised controlled trial.

Authors:  Milo A Puhan; Alex Suarez; Christian Lo Cascio; Alfred Zahn; Markus Heitz; Otto Braendli
Journal:  BMJ       Date:  2005-12-23

2.  Composite Pain Index: Reliability, Validity, and Sensitivity of a Patient-Reported Outcome for Research.

Authors:  Diana J Wilkie; Robert E Molokie; Marie L Suarez; Miriam O Ezenwa; Zaijie J Wang
Journal:  Pain Med       Date:  2015-02-25       Impact factor: 3.750

3.  Racial Disparities in Pain Management in Primary Care.

Authors:  Miriam O Ezenwa; Michael F Fleming
Journal:  J Health Dispar Res Pract       Date:  2012

Review 4.  Single versus multiple drug focus in substance abuse clinical trials research.

Authors:  Bruce J Rounsaville; Nancy M Petry; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2003-05-21       Impact factor: 4.492

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.